Fig. 8From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant propertiesAntioxidant activity of compounds 1, 3, 6, 7a, 7b, 7c, 7d, 7e, 8a and 8eBack to article page